πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≀24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β€” use filters for patent-cliff planning.

Page 77 of 173

  1. US 9744126

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9744214

    Methods and compositions for modulating myofibroblast activities

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9744169

    Compounds for treatment of fibrosis diseases

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9745266

    Indoline alkaloid compounds

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9744142

    Formulations of volatile anesthetics and methods of use for reducing inflammation

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9744235

    Treatment of cardiovascular disorders with targeted nanoparticles

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9745255

    Meta-substituted biphenyl peripherally restricted FAAH inhibitors

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9745376

    Anti-Ξ±Ξ½Ξ²6 antibodies

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9745314

    MDM2 inhibitors and therapeutic methods using the same

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9737598

    CD200 inhibitors and methods of use thereof

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9737525

    Small molecule activators of NRF2 pathway

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9737564

    Citrate containing beverage

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9737546

    Small molecules to enhance P53 activity

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9737527

    Biopolymer drug loading method

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9737512

    Methods and compositions for treating chronic pain

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9730894

    Stabilized HME composition with small drug particles

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9732386

    Cell aging as a unique biomarker of major depression

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9732114

    Compounds having anti-adhesive effects on cancer cells

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9732067

    Compounds and methods for activating the apoptotic arm of the unfolded protein response

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9731002

    HIV-1 GP 120 V1/V2 antigens and immunological uses thereof

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9731023

    Somatostatin receptor-based cancer therapy

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9730978

    Compositions for treating dry eye disease

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9730965

    Perivascular stem cell composition for bone

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9730954

    miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9730962

    Modalities for the treatment of degenerative diseases of the retina

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9724367

    Injectable formulations for organ augmentation

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9724387

    Administration of growth factors for the treatment of CNS disorders

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9724417

    Nanocarriers with multi-photon response elements

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9725520

    HER3 specific monoclonal antibodies for diagnostic and therapeutic use

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9725484

    Methods and compositions for the treatment of bone remodeling disorders

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9725460

    Oridonin analogs, compositions, and methods related thereto

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9724408

    Compositions and methods for activating stimulator of interferon gene-dependent signalling

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9724344

    Enhanced delivery of drug compositions to treat life threatening infections

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9724262

    Methods of diagnosing and treating neonatal reversion to fetal consciousness

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9717660

    Fluoride releasing dental composition and dental appliance

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9719088

    Micro-RNA family that modulates fibrosis and uses thereof

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9719087

    Micro-RNA family that modulates fibrosis and uses thereof

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9718921

    Amphiphilic derivatives of thioether containing block copolypeptides

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9718778

    Mixed disulfide conjugates of thienopyridine compounds and uses thereof

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9719144

    Microbiome markers and therapies for autism spectrum disorders

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9717827

    Immunomodulatory materials for implantable medical devices

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9717742

    Oxysterol analogue OXY133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9719086

    Micro-RNA family that modulates fibrosis and uses thereof

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9714288

    Antisense compounds and uses thereof

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9713612

    Compounds for treatment of cancer

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9713607

    Salinosporamides and methods of use thereof

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9713628

    Transplantation of neural cells

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9713459

    Method and system for in vivo hydrogen peroxide detection with ultrasound

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.